Links

How do companies decide which drugs to develop?“attending a more selective college causally reduces obesity”28% of patients with HIV were covered by MedicareThe AI Scientist + End-to-end causal effect estimation Development approval timelines and new housing supply in LA

Read More

FTC to sue PBMs over insulin pricing and rebates

From the FTC’s press release out today: Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’…

Read More

Clinician Adoption: How HealthTech Can Overcome Key Barriers

Even the most promising medical advancements struggle to take off in real-world settings without clinician buy-in. Here are some key factors that affect clinician adoption and ways healthtech companies can better position their innovations for success. The post Clinician Adoption: How HealthTech Can Overcome Key Barriers appeared first on MedCity News.

Read More

Weekend Links

Emily Oster on the power of nuance in public health.When did sustained economic growth begin?NYT: Rethinking drinking?Lex Fridman interviews Javier Milei (en español).Dumbest state “law” of the month

Read More